Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on tiotropium HandiHaler vs increased ICS dose in moderate and severe adult asthma controlled with ICS/LABA
TCTR20201111002Phase 3Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiotropium in asthma, sponsored by Ratchadaphiseksomphot Endowment Fund. Started Jun 2020; status: recruiting.
02
Drugs
tiotropium
03
Conditions
asthma
Beyond the preview
Go deeper on TCTR20201111002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201111002.